The process and outcomes of a nurse-led colorectal cancer follow-up clinic

Aim Evidence suggests that follow‐up after colorectal cancer improves survival. Colorectal cancer is so common that patient follow‐up can overwhelm a service, affecting the ability to see new referrals and reassess patients seen previously who have new symptoms. In order to cope with this demand a nurse‐led follow‐up service was started in 2004. We aimed to review the results of a nurse‐led colorectal cancer follow‐up clinic. Method Between 1 December 2004 and 31 January 2011, patients who underwent resection for colorectal cancer were followed up by a nurse specialist according to a protocol determined by the colorectal surgeons in the unit. All patient details were recorded prospectively in a purpose designed database. Results Nine hundred and fifty patients were followed up over 7 years. Some 368 patients were discharged from the follow‐up programme, 474 patients remain actively involved in the programme and 108 patients died. Of the patients discharged from the follow‐up scheme 269 (73%) were discharged to their general practitioner free of disease after 5 years. Of the 108 who patients died, 98 were as a result of colorectal cancer. Twenty patients (2.1%) were identified with local (peri‐anastomotic) disease recurrence and 93 patients (9.8%) were found to have developed distant metastatic disease. Of these, 65 patients (6.8%) were referred for palliative care and 28 (2.9%) had surgery for focal metastatic disease of whom 18 were still alive at the time of this analysis. Conclusion This paper shows that a nurse‐led clinic for colorectal cancer follow‐up can achieve satisfactory results with detection rates of recurrent or metastatic disease comparable to consultant follow‐up. A nurse‐led clinic provides the benefits of follow‐up without overwhelming the consultant colorectal surgical clinic practice.     

胃癌术后患者早期肠内营养达标状况及其影响因素研究

目的了解胃癌术后患者早期肠内营养达标状况,分析影响营养达标的因素,为进一步制定有效护理措施改善胃癌术后患者营养支持状况提供参考。方法根据肠内营养制剂第3天供给热量能否达到患者需求[104.6kJ/(kg.d)]的60%,将82例患者分为达标组和未达标组,分析比较两组患者的一般资料及临床特征,通过Logistic回归进行多因素分析,探讨影响早期肠内营养达标的主要因素。结果82例患者中17例(20.73%)达标。达标组患者体质量水平、术中出血量、肠内营养不耐受例数显著低于/少于未达标组(P<0.05,P<0.01)。Logistic回归分析显示,患者体质量、术中失血量、肠内营养不耐受对早期营养达标有影响。结论胃癌术后早期肠内营养实施状况有待进一步提高,体质量越重、术中失血量越多、肠内营养不耐受发生率越高的患者早期肠内营养不达标的危险大。     

腹腔镜胆囊切除术后随访分析

目的 对4000例腹腔镜胆囊切除术（Laparoscopic Cholecystectomy,LC)患者术后并发症及远期疗效作出分析。方法 随机对我院1991年3月-2001年12月4000例LC患者进行跟踪随访，回顾和统计分析。结果 随访3538例。主要不良反应及并发症有；右上腹疼痛，腹胀不适72例，伴恶心，有发热，黄疸者18例，长期腹泻患者19例，返流性胃炎6例，肝外胆管残留结石21例，并发肝癌2例，胆管狭窄2例。LC术后急性胰腺炎5例。胆囊切除术后综合征24例。结论 LC术后随访有利于对疗效及远期并发症的观察。有利于对腹腔镜胆囊切除操作技术的提高，LC术后随访对降低LC手术远期并发症有重要意义。     

心脏瓣膜置换术后中远期疗效分析

目的　分析探讨心脏瓣膜置换术的中远期疗效。方法　 1978年至 2 0 0 1年 12月 ,行瓣膜置换手术 2 14 1例 ,同期随访 16 81例 ,计 80 2 1 1人·年 ,平均 4 77人·年。通过回顾病因、手术方式、瓣膜类型等因素 ,观察术后病人心功能改善情况 ,病死率及并发症等 ,采用t检验 ,多因素回归等统计学方法分析。结果　 92例死亡。总体生存率 5年为 (92 3± 2 2 ) % ,10年生存率为 (90 1± 2 7) %。并发症有血栓栓塞、机械瓣膜功能障碍、瓣周漏、溶血、机械瓣膜感染性心内膜炎。术后心功能 (NYHA)与术前比较有明显的提高。结论　 1.机械瓣置换术后中远期疗效满意 ,病死率及并发症均较低 ;与术前心功能和手术种类直接相关 ;2 .使用保留瓣下结构及三尖瓣成形术对术后心功能恢复有明显效果 ;3.术中良好心肌保护是提高手术成功率的关键。     

强直性脊柱炎非骨水泥型全髋关节置换术后中期随访

目的:观察强直性脊柱炎非骨水泥型全髋关节置换术后中期的随访结果。方法:对37例(52髋)强直性脊柱炎非骨水泥型全髋关节置换术后患者进行了24～172个月,平均69个月的随访。临床随访根据Harris的评分方法进行评分,X线随访根据Gruen等和DeLee and Charnley分区法分别进行股骨柄和臼杯X线分析,根据Brooker等0～4级分级法进行异位骨化分级。结果:患者髋关节屈伸、收展、内外旋总活动度由术前的平均27°提高到术后平均152°。术后无脱位、感染等并发症发生。Harris评分术前平均为32(8～64)分,术后平均为82(64～96)分,其中优38髋,良8髋,可6髋,优良率88.5％。X线片分析未见假体松动,11髋(21.2％)发生异位骨化。结论:人工全髋关节置换术治疗强直性脊柱炎髋关节病变,中期可取得满意的临床效果。     

Five‐year follow‐up after live donor nephrectomy – cross‐sectional and longitudinal analysis of a prospective cohort within the era of extended donor eligibility criteria

To establish the outcome of live kidney donors 5 years after donation, we investigated the risk for progressive renal function decline and quality of life (QoL). Data on estimated glomerular filtration rate (eGFR), creatinine, hypertension, QoL and survival were assessed in a prospective cohort of 190 donors, who donated between 2008 and 2010. Data were available for >90%. The mean age predonation was 52.8 ± 11.5 years, 30 donors having pre‐existent hypertension. The mean follow‐up was 5.1 ± 0.9 years. Eight donors had died due to non‐donation‐related causes. After 5 years, the mean eGFR was 60.2 (95% CI 58.7–62.7) ml/min/1.73 mup>2up>, with a median serum creatinine of 105.1 (95% CI 102.5–107.8) μmol/l. eGFR decreased to 33.6% and was longitudinally lower among men than women and declining with age (P < 0.001), without any association on QoL. Donors with pre‐existent and new‐onset hypertension demonstrated no progressive decline of renal function overtime compared to nonhypertensives. No donors were found with proteinuria, microalbuminuria or at risk for end‐stage renal disease. After an initial decline postdonation, renal function remained unchanged overtime. Men and ageing seem to affect renal function overtime, while decreased renal function did not affect QoL. These data support further stimulation of living kidney donation programmes as seen from the perspective of donor safety.     

The Living Donor Collective: A Scientific Registry for Living Donors

In the setting of an overall decline in living organ donation and new questions about long‐term safety, a better understanding of outcomes after living donation has become imperative. Adequate information on outcomes important to donors may take many years to ascertain and may be evident only by comparing large numbers of donors with suitable controls. Previous studies have been unable to fully answer critical questions, primarily due to lack of appropriate controls, inadequate sample size, and/or follow‐up duration that is too short to allow detection of important risks attributable to donation. The Organ Procurement and Transplantation Network does not follow donors long term and has no prospective control group with which to compare postdonation outcomes. There is a need to establish a national living donor registry and to prospectively follow donors over their lifetimes. In addition, there is a need to better understand the reasons many potential donors who volunteer to donate do not donate and whether the reasons are justified. Therefore, the US Health Resources and Services Administration asked the Scientific Registry of Transplant Recipients to establish a national registry to address these important questions. Here, we discuss the efforts, challenges, and opportunities inherent in establishing the Living Donor Collective.     

经皮空心松质骨螺钉治疗HerbertⅠ型腕舟骨骨折的临床研究

目的对比研究经皮空心松质骨螺钉和石膏外固定治疗HerbertⅠ型腕舟骨骨折的临床效果。方法对46例新鲜无移位HerbertⅠ型腕舟骨骨折,随机分成两组,螺钉组(26例)和石膏组(20例),术后或石膏固定后每2周腕关节拍摄计算机辅助X线片1次,直至骨折愈合;对骨折愈合时间、恢复工作时间和腕关节活动度及握力进行对比性研究。结果术后随访10～27个月,平均18.3个月。骨折愈合时间:螺钉组26例骨折全部骨性愈合(100%),平均愈合时间为7.5周;石膏组20例中18例骨性愈合(90%),平均愈合时间为13.5周,两组差异有统计学意义(P<0.01)。恢复工作时间:螺钉组平均为8.9周,石膏组为15.7周(P<0.01)。腕关节活动度和握力两组间差异无统计学意义。结论经皮空心松质骨螺钉在HerbertⅠ型腕舟骨骨折治疗中手术操作简单,创伤小,疗效明显优于石膏固定。     

胸廓出口综合征26例术后远期疗效分析

目的 报道胸廓出口综合征（thoracic outlet syndrome，TOS）手术治疗后的远期疗效。方法 对26例胸廓出口综合征患者．切断前、中、小斜角肌及臂丛神经松解术后进行5年3个月-10年7个月的长期随访，并分析其疗效。结果 14例颈肩部疼痛、手麻症状消失，6例症状明显好转，6例自觉效果不佳或无效，优良率为76．93％。结论 胸廓出口综合征是常见病，一旦确诊，保守治疗效果不佳或反复发作者，应及早手术。但必需注意术后大约有23．07％的患者效果不佳甚至无效。